Population pharmacokinetics of tacrolimus and CYP3A5-driven variability: implications for model-informed dose individualization in pediatric renal transplant recipients.
- DOI
- 10.1186/s40360-026-01157-5
- Published
- 2026 Jun 13
- Container
- BMC pharmacology & toxicology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40360-026-01157-5,
title = {Population pharmacokinetics of tacrolimus and CYP3A5-driven variability: implications for model-informed dose individualization in pediatric renal transplant recipients.},
author = {Xajil-Ramos LY and Gándara-Mireles JA and Guerra-García M and Rosales RJV and Toledo AMR and Ocaña-Garrido DS and Lares-Asseff I and Cóbar O and Soveranis SM and Patrón-Romero L and Almanza-Reyes H and Lou-Meda R},
year = {2026},
journal = {BMC pharmacology \& toxicology},
doi = {10.1186/s40360-026-01157-5},
url = {https://doi.org/10.1186/s40360-026-01157-5}
}RIS
TY - JOUR TI - Population pharmacokinetics of tacrolimus and CYP3A5-driven variability: implications for model-informed dose individualization in pediatric renal transplant recipients. AU - Xajil-Ramos LY AU - Gándara-Mireles JA AU - Guerra-García M AU - Rosales RJV AU - Toledo AMR AU - Ocaña-Garrido DS AU - Lares-Asseff I AU - Cóbar O AU - Soveranis SM AU - Patrón-Romero L AU - Almanza-Reyes H AU - Lou-Meda R PY - 2026 JO - BMC pharmacology & toxicology DO - 10.1186/s40360-026-01157-5 UR - https://doi.org/10.1186/s40360-026-01157-5 ER -
APA
LY, X., JA, G., M, G., RJV, R., AMR, T., DS, O., I, L., O, C., SM, S., L, P., H, A., & R, L. (2026). Population pharmacokinetics of tacrolimus and CYP3A5-driven variability: implications for model-informed dose individualization in pediatric renal transplant recipients.. BMC pharmacology & toxicology. https://doi.org/10.1186/s40360-026-01157-5
Source records
- pubmed · retrieved 2026-09-26T05:22:32.790Z